- 专利标题： Blood glucose control system with medicament bolus recommendation
-
申请号： US17062436申请日： 2020-10-02
-
公开(公告)号： US11154656B2公开(公告)日： 2021-10-26
- 发明人: Firas H. El-Khatib , Edward R. Damiano , Edward B. Raskin , David Chi-Wai Lim , Michael J. Rosinko , John R. Costik
- 申请人： Beta Bionics, Inc.
- 申请人地址： US MA Concord
- 专利权人： Beta Bionics, Inc.
- 当前专利权人： Beta Bionics, Inc.
- 当前专利权人地址： US MA Concord
- 代理机构： Knobbe Martens Olson & Bear, LLP
- 主分类号： A61M5/172
- IPC分类号： A61M5/172 ; A61M5/142 ; G16H20/17 ; G16H40/40 ; G06F8/656 ; H04W76/10 ; G06F8/61 ; H04L29/08 ; G16H40/60 ; G16H80/00 ; A61M5/168 ; G08B21/04 ; G08B21/18 ; G16H40/67 ; G06F21/30 ; G06F21/31 ; G06F21/62 ; G06F21/84 ; G16H10/60 ; G16H50/30 ; G06F3/0488 ; G06F8/65 ; H04L29/06 ; H04W76/14 ; H04L9/08 ; H04L9/30 ; G06F3/0484 ; G08B25/00 ; A61B5/145 ; G16H40/00
摘要：
An automated blood glucose control system can provide automatic delivery of glucose control therapy to a subject and receive information about manual glucose control therapy provided to the subject. The automated blood glucose control system can indicate an amount of a bolus of medicament via a control algorithm configured to control blood glucose level in the subject. The automated blood glucose control system can indicate an amount of a manual bolus of medicament, which can be used to model a diminishment of the medicament in the subject over time based at least in part on the manual bolus of medicament.
公开/授权文献
信息查询
IPC分类:
